"Researchers identified UNI418, a molecule that destabilizes DNA repair proteins in cancer cells. UNI418 activates the Cul4A ubiquitin ligase complex, leading to the degradation of RAD51 and CHK1. The treatment re-sensitizes resistant cancer cells to PARP inhibitors."